UPDATE 3-GSK stays strong as healthy sales beat expectations ...Middle East

GSK began 2023 with a quarterly performance that beat analyst expectations and extended a series of positive results following strong sales of its roster of vaccines as well as HIV and respiratory medicines. It reaffirmed its guidance for 2023, saying it expected adjusted operating profit growth to be higher in the second half, but lower in the first half of the year when expected drug launches will increase costs.

Read More Details
Finally We wish PressBee provided you with enough information of ( UPDATE 3-GSK stays strong as healthy sales beat expectations )

Also on site :

• Ott Tanak Aims for Hyundai's First Victory Amidst Heated Acropolis Rally
• This 10-year plan may be the last chance to save the NHS
• Jasprit Bumrah Returns to Nets Ahead of Crucial Test Match